FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 151 filers reported holding FATE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.11 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $2,110,000 | +46.0% | 23,209 | -35.8% | 0.35% | +0.9% |
| Q3 2020 | $1,445,000 | -15.9% | 36,160 | -27.8% | 0.34% | -9.7% |
| Q2 2020 | $1,719,000 | +14.4% | 50,110 | -25.9% | 0.38% | -18.5% |
| Q1 2020 | $1,502,000 | +150.8% | 67,647 | +75.5% | 0.47% | +194.9% |
| Q3 2019 | $599,000 | -58.3% | 38,540 | -45.6% | 0.16% | -55.0% |
| Q2 2019 | $1,437,000 | +15.5% | 70,799 | 0.0% | 0.35% | +15.1% |
| Q1 2019 | $1,244,000 | +21.6% | 70,799 | -11.2% | 0.30% | +9.7% |
| Q4 2018 | $1,023,000 | -23.2% | 79,716 | -2.5% | 0.28% | +40.4% |
| Q3 2018 | $1,332,000 | +90.6% | 81,743 | +32.5% | 0.20% | +80.0% |
| Q2 2018 | $699,000 | -74.3% | 61,681 | -77.9% | 0.11% | -75.8% |
| Q1 2018 | $2,725,000 | – | 279,161 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $7,163,616 | 2.64% |
| Redmile Group, LLC | 13,124,427 | $27,823,785 | 1.32% |
| Monaco Asset Management SAM | 1,847,944 | $3,917,641 | 1.16% |
| Casdin Capital, LLC | 2,050,000 | $4,346,000 | 0.48% |
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $1,484,000 | 0.21% |
| GCM Grosvenor Holdings, LLC | 495,916 | $1,051,342 | 0.21% |
| Nebula Research & Development LLC | 163,617 | $346,868 | 0.18% |
| Bellevue Group AG | 4,851,579 | $10,285,347 | 0.17% |
| Bruce & Co., Inc. | 200,000 | $424,000 | 0.14% |
| XTX Topco Ltd | 192,920 | $408,990 | 0.07% |